Trial intelligence / Profile preview

Zolpidem-MR as needed in chronic primary insomnia

NCT00425243Phase 3Completed

Sponsor
Sanofi
Start
Aug 2004
Primary completion
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of zolpidem in Chronic Primary Insomnia, sponsored by Sanofi. Started Aug 2004; status: completed.

02

Drugs

zolpidem
03

Conditions

Chronic Primary Insomnia

Beyond the preview

Go deeper on NCT00425243.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00425243.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call